<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32274530</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1435-1250</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Zeitschrift fur Rheumatologie</Title><ISOAbbreviation>Z Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Association of HLA-G polymorphisms with systemic lupus erythematosus and correlation between soluble HLA&#x2011;G levels and the disease: a&#xa0;meta-analysis.</ArticleTitle><Pagination><StartPage>96</StartPage><EndPage>102</EndPage><MedlinePgn>96-102</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00393-020-00783-6</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the association between HLA&#x2011;G polymorphisms and systemic lupus erythematosus (SLE) susceptibility as well as the relationship between circulating soluble HLA&#x2011;G (sHLA&#x2011;G) levels and SLE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A&#xa0;meta-analysis was performed to investigate the relationships between HLA&#x2011;G 14-bp insertion&#xa0;(I)/deletion&#xa0;(D), +3142&#x202f;G/C, +3035&#x202f;T/C, and +3003&#x202f;C/T polymorphisms and SLE as well as the relationship between sHLA&#x2011;G serum/plasma levels in SLE patients and controls.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven publications fulfilled our inclusion criteria. Meta-analysis under the dominant model showed an association in the overall group between the II+ID genotype of HLA&#x2011;G 14-bp I/D polymorphism and SLE (OR&#x202f;=&#x2009;1.213, 95%CI&#x202f;=&#x2009;1.077-1.365, P&#x202f;=&#x2009;0.001). Ethnicity-specific meta-analysis showed an association between II+ID and SLE in Asians but not in South American and European populations. No correlation was observed using the allele contrast between HLA&#x2011;G +3142&#x202f;G/C polymorphisms and SLE. Contrastingly, +3035&#x202f;T/C and +3003&#x202f;C/T meta-analysis showed a&#xa0;significant allelic association between SLE and HLA&#x2011;G polymorphisms (OR&#x202f;=&#x2009;1.378, 95%CI&#x202f;=&#x2009;1.109-1.713, P&#x202f;=&#x2009;0.004; OR&#x202f;=&#x2009;1.834, 95%CI&#x202f;=&#x2009;1.112-3.022, P&#x202f;=&#x2009;0.017; respectively). sHLA&#x2011;G levels were significantly higher in the SLE group than in the controls (SMD&#x202f;=&#x2009;0.637, 95%CI&#x202f;=&#x2009;0.382-0.892, P&#x202f;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We showed association of HLA&#x2011;G 14-bp I/D, +3035&#x202f;T/C, and +3003&#x202f;C/T polymorphisms with SLE susceptibility and significantly higher circulating sHLA&#x2011;G levels in SLE patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sang-Cheol</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea (Republic of).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Young Ho</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Korea University Anam Hospital, Korea University College of Medicine, 73, Goryeodae-ro, Seongbuk-gu, 02841, Seoul, Korea (Republic of). lyhcgh@korea.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><VernacularTitle>Zusammenhang von HLA-G-Polymorphismen mit systemischem Lupus erythematosus und Korrelation zwischen Werten f&#xfc;r l&#xf6;sliches HLA-G und der Erkrankung: eine Metaanalyse.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Z Rheumatol</MedlineTA><NlmUniqueID>0414162</NlmUniqueID><ISSNLinking>0340-1855</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059951">HLA-G Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059951" MajorTopicYN="N">HLA-G Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="ZUSAMMENFASSUNG" NlmCategory="UNASSIGNED">ZIEL DER ARBEIT: Ziel war es, den Zusammenhang zwischen HLA-G-Polymorphismen und der Anf&#xe4;lligkeit f&#xfc;r systemischen Lupus erythematosus (SLE) sowie die Beziehung zwischen den Werten f&#xfc;r zirkulierendes l&#xf6;sliches HLA&#x2011;G (sHLA&#x2011;G) und SLE zu untersuchen.</AbstractText><AbstractText Label="METHODEN" NlmCategory="METHODS">Es wurde eine Metaanalyse durchgef&#xfc;hrt, um die Beziehungen zwischen HLA&#x2011;G-14-bp-Insertion&#xa0;(I)/-Deletion&#xa0;(D), +3142&#x202f;G/C-, +3035&#x202f;T/C- und +3003&#x202f;C/T-Polymorphismen und SLE sowie die Beziehung zwischen sHLA-G-Serum&#x2011;/Plasmawerten bei SLE-Patienten und Kontrollen zu erfassen.</AbstractText><AbstractText Label="ERGEBNISSE" NlmCategory="UNASSIGNED">Die Einschlusskriterien der Autoren wurden von 11 Publikationen erf&#xfc;llt. Eine Metaanalyse unter Einbezug des dominanten Modells zeigte in der Gesamtgruppe einen Zusammenhang zwischen dem II+ID-Genotyp des HLA&#x2011;G-14-bp-I/D-Polymorphismus und SLE (Odds Ratio, OR: 1,213; 95%-Konfidenzintervall, 95%-KI: 1,077&#x2013;1,365; p&#x202f;=&#x2009;0,001). Die ethnizit&#xe4;tsspezifische Metaanalyse ergab einen Zusammenhang zwischen II+ID und SLE bei Asiaten, nicht aber in s&#xfc;damerikanischen und europ&#xe4;ischen Populationen. Es fand sich keine Korrelation bei Verwendung des Allelkontrasts zwischen HLA&#x2011;G-+3142&#x202f;G/C-Polymorphismen und SLE. Dagegen zeigte die +3035&#x202f;T/C- und +3003&#x202f;C/T-Metaanalyse eine signifikante allelische Assoziation zwischen SLE und HLA-G-Polymorphismen (OR: 1,378; 95%-KI: 1,109&#x2013;1,713; p&#x202f;=&#x2009;0,004 bzw. OR: 1,834; 95%-KI: 1,112&#x2013;3,022; p&#x202f;=&#x2009;0,017). Die sHLA-G-Werte waren in der SLE-Gruppe signifikant h&#xf6;her als bei den Kontrollen (standardisierte Mittelwertdifferenz, SMD: 0,637; 95%-KI: 0,382&#x2013;0,892; p&#x202f;&lt;&#x2009;0,001).</AbstractText><AbstractText Label="SCHLUSSFOLGERUNG" NlmCategory="UNASSIGNED">Die Autoren zeigten einen Zusammenhang der HLA&#x2011;G-14-bp-I/D-, +3035&#x202f;T/C- und +3003&#x202f;C/T-Polymorphismen mit der Anf&#xe4;lligkeit f&#xfc;r SLE und signifikant erh&#xf6;hten zirkulierenden sHLA-G-Werten bei SLE-Patienten.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HLA&#x2011;G</Keyword><Keyword MajorTopicYN="N">Level</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Polymorphism</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32274530</ArticleId><ArticleId IdType="doi">10.1007/s00393-020-00783-6</ArticleId><ArticleId IdType="pii">10.1007/s00393-020-00783-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ruiz-Irastorza&#xa0;G, Khamashta&#xa0;MA, Castellino&#xa0;G, Hughes&#xa0;GR (2001) Systemic lupus erythematosus. Lancet 357:1027&#x2013;1032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)04239-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotzin&#xa0;BL (1996) Systemic lupus erythematosus. Cell 85:303&#x2013;306</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81108-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee&#xa0;YH, Bae&#xa0;S&#x2011;C, Choi&#xa0;SJ, Ji&#xa0;JD, Song&#xa0;GG (2012) Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis. Mol Biol Rep 39:10627&#x2013;10635</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-012-1952-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorling&#xa0;A, Monk&#xa0;NJ, Lechler&#xa0;RI (2000) HLA&#x2011;G inhibits the transendothelial migration of human NK cells. Eur J Immunol 30:586&#x2013;593</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1521-4141(200002)30:2&lt;586::AID-IMMU586&gt;3.0.CO;2-Y</ArticleId></ArticleIdList></Reference><Reference><Citation>Bainbridge&#xa0;DR, Ellis&#xa0;SA, Sargent&#xa0;IL (2000) HLA&#x2011;G suppresses proliferation of CD4(+) T&#x2011;lymphocytes. J&#xa0;Reprod Immunol 48:17&#x2013;26</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0378(00)00070-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau&#xa0;P, Le Discorde&#xa0;M, Mouillot&#xa0;G, Marcou&#xa0;C, Carosella&#xa0;ED, Moreau&#xa0;P (2003) The 14&#x202f;bp deletion-insertion polymorphism in the 3&#x2032; UT region of the HLA&#x2011;G gene influences HLA&#x2011;G mRNA stability. Hum Immunol 64:1005&#x2013;1010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2003.08.347</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti&#xa0;A, Almeida&#xa0;R, Mesquita&#xa0;Z, Duarte&#xa0;A, Donadi&#xa0;EA, Lucena-Silva&#xa0;N (2017) Gene polymorphism and HLA&#x2011;G expression in patients with childhood-onset systemic lupus erythematosus: a pilot study. HLA 90:219&#x2013;227</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.13084</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachiya&#xa0;Y, Kawasaki&#xa0;A, Oka&#xa0;S et al (2016) Association of HLA&#x2011;G 3&#x2032; untranslated region polymorphisms with systemic lupus erythematosus in a&#xa0;Japanese population: a case-control association study. PLoS One 11:e158065</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0158065</ArticleId></ArticleIdList></Reference><Reference><Citation>Catamo&#xa0;E, Addobbati&#xa0;C, Segat&#xa0;L et al (2015) Comprehensive analysis of polymorphisms in the HLA&#x2011;G 5&#x2032; upstream regulatory and 3&#x2032; untranslated regions in Brazilian patients with systemic lupus erythematosus. Tissue Antigens 85:458&#x2013;465</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.12545</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen&#xa0;T, Lin&#xa0;J, Jin&#xa0;S, Ma&#xa0;S, Yu&#xa0;L, Huang&#xa0;K, Huang&#xa0;X, Chu&#xa0;J, Yang&#xa0;Z (2014) Association of three polymorphisms in the 3&#x2032; untranslated region of the HLA&#x2011;G gene with systemic lupus erythematosus in a&#xa0;population from Yunnan. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 31:228&#x2013;232</Citation><ArticleIdList><ArticleId IdType="pubmed">24711038</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucena-Silva&#xa0;N, de Souza&#xa0;VS, Gomes&#xa0;RG et al (2013) HLA&#x2011;G 3&#x2032; untranslated region polymorphisms are associated with systemic lupus erythematosus in 2 Brazilian populations. J&#xa0;Rheumatol 40:1104&#x2013;1113</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.120814</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio&#xa0;CR, Veit&#xa0;TD, Monticielo&#xa0;OA, Mucenic&#xa0;T, Xavier&#xa0;RM, Brenol&#xa0;JC, Chies&#xa0;JA (2011) Association of the HLA&#x2011;G gene +3142C&gt;G polymorphism with systemic lupus erythematosus. Tissue Antigens 77:540&#x2013;545</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2011.01635.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu&#xa0;FX, Wu&#xa0;LJ, Luo&#xa0;XY, Tang&#xa0;Z, Yang&#xa0;MH, Xie&#xa0;CM, Liu&#xa0;NT, Zhou&#xa0;JG, Guan&#xa0;JL, Yuan&#xa0;GH (2009) Lack of association between HLA&#x2011;G 14-bp polymorphism and systemic lupus erythematosus in a&#xa0;Han Chinese population. Lupus 18:1259&#x2013;1266</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309345756</ArticleId></ArticleIdList></Reference><Reference><Citation>Veit&#xa0;TD, Cordero&#xa0;EA, Mucenic&#xa0;T, Monticielo&#xa0;OA, Brenol&#xa0;JC, Xavier&#xa0;RM, Delgado-Canedo&#xa0;A, Chies&#xa0;JA (2009) Association of the HLA&#x2011;G 14&#x202f;bp polymorphism with systemic lupus erythematosus. Lupus 18:424&#x2013;430</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308098187</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo&#xa0;R, Hviid&#xa0;TV, Govoni&#xa0;M et al (2008) HLA&#x2011;G genotype and HLA&#x2011;G expression in systemic lupus erythematosus: HLA&#x2011;G as a&#xa0;putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 71:520&#x2013;529</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2008.01037.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Salloom&#xa0;DF, Abdullah&#xa0;HN, Hadi&#xa0;YA (2019) Association of HLA-G+ 3142G&gt;C gene polymorphism and toll-like receptor&#x2011;9 serum level in systemic lupus erythematosus patients. Meta Gene 21:100582</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mgene.2019.100582</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen&#xa0;C, Liang&#xa0;J, Yao&#xa0;G, Chen&#xa0;H, Shi&#xa0;B, Zhang&#xa0;Z, Zhao&#xa0;C, Zhang&#xa0;H, Sun&#xa0;L (2017) Mesenchymal stem cells upregulate Treg cells via sHLA&#x2011;G in SLE patients. Int Immunopharmacol 44:234&#x2013;241</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2017.01.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Song&#xa0;GG, Bae&#xa0;S&#x2011;C, Lee&#xa0;YH (2012) Association between vitamin D intake and the risk of rheumatoid arthritis: a&#xa0;meta-analysis. Clin Rheumatol 31:1733&#x2013;1739</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-012-2080-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee&#xa0;YH (2018) Association between the neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and rheumatoid arthritis and their correlations with the disease activity: a meta-analysis. J&#xa0;Rheum Dis 25:169&#x2013;178</Citation><ArticleIdList><ArticleId IdType="doi">10.4078/jrd.2018.25.3.169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee&#xa0;YH, Bae&#xa0;S&#x2011;C, Choi&#xa0;SJ, Ji&#xa0;JD, Song&#xa0;GG (2012) The association between the PTPN22 C1858T polymorphism and rheumatoid arthritis: a&#xa0;meta-analysis update. Mol Biol Rep 39:3453&#x2013;3460</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-011-1117-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher&#xa0;D, Liberati&#xa0;A, Tetzlaff&#xa0;J, Altman&#xa0;DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger&#xa0;M, Smith&#xa0;GD, Phillips&#xa0;AN (1997) Meta-analysis: principles and procedures. BMJ 315:1533&#x2013;1537</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7121.1533</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian&#xa0;R, Laird&#xa0;N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177&#x2013;188</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul&#xa0;F, Erdfelder&#xa0;E, Buchner&#xa0;A, Lang&#xa0;AG (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41:1149&#x2013;1160</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BRM.41.4.1149</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger&#xa0;M, Davey Smith&#xa0;G, Schneider&#xa0;M, Minder&#xa0;C (1997) Bias in meta-analysis detected by a&#xa0;simple, graphical test. BMJ 315:629&#x2013;634</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId></ArticleIdList></Reference><Reference><Citation>Veit&#xa0;TD, de Lima&#xa0;CP, Cavalheiro&#xa0;LC, Callegari-Jacques&#xa0;SM, Brenol&#xa0;CV, Brenol&#xa0;JC, Xavier&#xa0;RM, da Cunha Sauma&#xa0;MF, dos Santos&#xa0;EJ, Chies&#xa0;JA (2014) HLA&#x2011;G +3142 polymorphism as a&#xa0;susceptibility marker in two rheumatoid arthritis populations in Brazil. Tissue Antigens 83:260&#x2013;266</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.12311</ArticleId></ArticleIdList></Reference><Reference><Citation>Carosella&#xa0;ED, Moreau&#xa0;P, Aractingi&#xa0;S, Rouas-Freiss&#xa0;N (2001) HLA-G: a&#xa0;shield against inflammatory aggression. Trends Immunol 22:553&#x2013;555</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1471-4906(01)02007-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan&#xa0;Z, Randall&#xa0;G, Fan&#xa0;J et al (2007) Allele-specific targeting of microRNAs to HLA&#x2011;G and risk of asthma. Am J Hum Genet 81:829&#x2013;834</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/521200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee&#xa0;YH, Bae&#xa0;S&#x2011;C, Song&#xa0;GG (2015) Meta-analysis of associations between functional HLA&#x2011;G polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int 35:953&#x2013;961</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-014-3155-3</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>